Mc Dowell Caryn Gordon Insider Trades

Insider Trading History

Track insider trading activity for Mc Dowell Caryn Gordon. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Revance Therapeutics
Revance Therapeutics RVNC
Svp, GC & Secretary
Holding Value $85.6k 23,453 shares
Last Trade
Feb 15, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$21.9k 864 shares
$25.33
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Svp, GC & Secretary
Holding Value $88.8k 24,317 shares
Last Trade
Dec 31, 2019 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$6.2k 382 shares
$16.23
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Svp, GC & Secretary
Holding Value $87.4k 23,935 shares
Last Trade
Jun 28, 2019 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$13k 1,000 shares
$12.97
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Svp, GC & Secretary
Holding Value $83.7k 22,935 shares
Last Trade
Jun 15, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$15k 1,383 shares
$10.86
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Svp, GC & Secretary
Holding Value $183k 50,000 shares
Last Trade
Jan 24, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$862k 50,000 shares
$17.23
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Svp, GC & Secretary
Holding Value $88.8k 24,318 shares
Last Trade
Jan 24, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$129k 7,500 shares
$17.23
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Svp, GC & Secretary
Holding Value $61.4k 16,818 shares
Last Trade
Dec 31, 2018 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$16.5k 818 shares
$20.13
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Svp, GC & Secretary
Holding Value $402k 110,000 shares
Last Trade
May 01, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.11M 110,000 shares
$28.30
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
Svp, GC & Secretary
Holding Value $58.4k 16,000 shares
Last Trade
May 01, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$453k 16,000 shares
$28.30
$3.65
Cytokinetics
Cytokinetics CYTK
GC & Chief Compliance Officer
Holding Value $2.35M 32,548 shares
Last Trade
Feb 28, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$19k 2,452 shares
$7.75
$72.29
Cytokinetics
Cytokinetics CYTK
GC & Chief Compliance Officer
Holding Value $1.1M 15,226 shares
Last Trade
Feb 27, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$119k 15,226 shares
$7.80
$72.29
Cytokinetics
Cytokinetics CYTK
GC & Chief Compliance Officer
Holding Value $1.07M 14,774 shares
Last Trade
Feb 27, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$115k 14,774 shares
$7.80
$72.29
Cytokinetics
Cytokinetics CYTK
GC & Chief Compliance Officer
Holding Value $2.53M 35,000 shares
Last Trade
Feb 27, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$156k 20,000 shares
$7.80
$72.29
Cytokinetics
Cytokinetics CYTK
GC & Chief Compliance Officer
Holding Value $66.6k 921 shares
Last Trade
Jan 16, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$662 77 shares
$8.60
$72.29
Cytokinetics
Cytokinetics CYTK
GC & Chief Compliance Officer
Holding Value $72.1k 998 shares
Last Trade
Jan 16, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$662 77 shares
$8.60
$72.29
Cytokinetics
Cytokinetics CYTK
GC & Chief Compliance Officer
Holding Value $1.13M 15,653 shares
Last Trade
Jan 16, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.62k 653 shares
$8.60
$72.29
Cytokinetics
Cytokinetics CYTK
GC & Chief Compliance Officer
Holding Value $768k 10,625 shares
Last Trade
Jan 16, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.38k 625 shares
$8.60
$72.29
Cytokinetics
Cytokinetics CYTK
GC & Chief Compliance Officer
Holding Value $813k 11,250 shares
Last Trade
Jan 16, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.38k 625 shares
$8.60
$72.29
Cytokinetics
Cytokinetics CYTK
GC & Chief Compliance Officer
Holding Value $1.3M 18,038 shares
Last Trade
Jan 16, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.62k 653 shares
$8.60
$72.29
Cytokinetics
Cytokinetics CYTK
GC & Chief Compliance Officer
Holding Value $1.08M 15,000 shares
Last Trade
Jan 16, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.63k 625 shares
$9.00
$72.29

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up